Affiliation:
1. Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
2. Numico Research, Friedrichsdorf, Germany
Abstract
Abstract
Background: The presence of the adipokines adiponectin and leptin in cord blood and placental and fetal tissues suggests a possible role in fetal development.
Methods: We measured concentrations of adiponectin and leptin in maternal serum, cord blood, and breast milk and examined their correlations within a large, population-based study. Between November 2000 and November 2001, we recruited all mothers and their newborns after delivery at the University of Ulm (Ulm, Germany). The current analysis included 766 mothers with available breast milk samples collected 6 weeks postpartum. Adipokine concentrations were measured with commercially available ELISAs (R&D Systems).
Results: Median adiponectin concentrations in maternal serum (n = 713), cord blood (n = 709), and breast milk (n = 766) were 8.6 mg/L, 30.6 mg/L, and 10.9 μg/L, respectively. Median leptin concentrations were 12.8 μg/L in maternal serum, 7.8 μg/L in cord blood, and 174.5 ng/L in breast milk. Whereas increases in leptin concentrations with increasing birth weight, birth weight according to gestational age, and ponderal index were statistically significant in cord blood (all P values <0.0001), cord blood adiponectin was clearly related only to birth weight (P = 0.0004). Concentrations of both adipokines were moderately correlated in breast milk and maternal serum (both Spearman ρ values were 0.43; P <0.0001).
Conclusions: Concentrations of adiponectin and leptin vary strongly in maternal serum, cord blood, and breast milk, with only moderate correlations between both adipokines in maternal serum and breast milk. The health implications of these patterns warrant further investigation.
Publisher
Oxford University Press (OUP)
Subject
Biochemistry (medical),Clinical Biochemistry
Reference43 articles.
1. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem2004;50:1511-1525.
2. Schondorf T, Maiworm A, Emmison N, Forst T, Pfutzner A. Biological background and role of adiponectin as marker for insulin resistance and cardiovascular risk. Clin Lab2005;51:489-494.
3. Haluzik M. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance. Curr Opin Investig Drugs2005;6:988-993.
4. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, et al. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med1997;3:1029-1033.
5. Lea RG, Howe D, Hannah LT, Bonneau O, Hunter L, Hoggard N. Placental leptin in normal, diabetic and fetal-growth-retarded pregnancies. Mol Hum Reprod2000;6:763-769.
Cited by
115 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献